Utility and cost-effectiveness of molecular testing in thyroid nodules with indeterminate cytology

Clinical Endocrinology

Volumn 85, Issue 4, 2016, Pages 624-631

  Labourier, Emmanuel ^a  

^a BMDx   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CYTOLOGY; FOLLOW UP; GENE EXPRESSION; HEALTH CARE COST; HUMAN; HYPOPARATHYROIDISM; HYPOTHYROIDISM; LARYNGEAL NERVE INJURY; PATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THYROID NODULE; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84988674544     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13096     Document Type: Article

References (32)

1. Haugen, B.R., Alexander, E.K., Bible, K.C. et al. (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26, 1–133.
2. Bongiovanni, M., Spitale, A., Faquin, W.C. et al. (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytologica, 56, 333–339.
3. Wang, C.C., Friedman, L., Kennedy, G.C. et al. (2011) A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid, 21, 243–251.
4. Ferris, R.L., Baloch, Z., Bernet, V. et al. (2015) American thyroid association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making. Thyroid, 25, 760–768.
5. Yip, L., Farris, C., Kabaker, A.S. et al. (2012) Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. The Journal of Clinical Endocrinology and Metabolism, 97, 1905–1912.
6. Li, H., Robinson, K.A., Anton, B. et al. (2011) Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. The Journal of Clinical Endocrinology and Metabolism, 96, E1719–E1726.
7. Lee, L., How, J., Tabah, R.J. et al. (2014) Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology. The Journal of Clinical Endocrinology and Metabolism, 99, 2674–2682.
8. Diggans, J., Kim, S.Y., Hu, Z. et al. (2015) Machine learning from concept to clinic: reliable detection of BRAF V600E DNA mutations in thyroid nodules using high-dimensional RNA expression data. Pacific Symposium on Biocomputing, 20, 371–382.
9. Labourier, E., Shifrin, A., Busseniers, A.E. et al. (2015) Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology. The Journal of Clinical Endocrinology and Metabolism, 100, 2743–2750.
10. Wylie, D., Beaudenon, S., Haynes, B.C. et al. (2016) Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations. The Journal of Pathology: Clinical Research, 100, 2743–2750.
11. Caro, J.J., Briggs, A.H., Siebert, U. et al. (2012) Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Medical Decision Making, 32, 667–677.
12. Gharib, H. & Papini, E. (2007) Thyroid nodules: clinical importance, assessment, and treatment. Endocrinology and Metabolism Clinics of North America, 36, 707–735.
13. Popoveniuc, G. & Jonklaas, J. (2012) Thyroid nodules. The Medical Clinics of North America, 96, 329–349.
14. Yang, J., Schnadig, V., Logrono, R. et al. (2007) Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer, 111, 306–315.
15. Yassa, L., Cibas, E.S., Benson, C.B. et al. (2007) Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer, 111, 508–516.
16. VanderLaan, P.A., Marqusee, E. & Krane, J.F. (2011) Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? American Journal of Clinical Pathology, 135, 770–775.
17. Nayar, R. & Ivanovic, M. (2009) The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer, 117, 195–202.
18. Nagarkatti, S.S., Faquin, W.C., Lubitz, C.C. et al. (2013) Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Annals of Surgical Oncology, 20, 60–65.
19. Ustun, H., Astarci, H.M., Altunkaya, C. et al. (2012) Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system. Acta Cytologica, 56, 361–369.
20. Alexander, E.K., Kennedy, G.C., Baloch, Z.W. et al. (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. The New England Journal of Medicine, 367, 705–715.
21. Kloos, R.T., Reynolds, J.D., Walsh, P.S. et al. (2013) Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules? The Journal of Clinical Endocrinology and Metabolism, 98, E761–E768.
22. Lubitz, C.C., Kong, C.Y., McMahon, P.M. et al. (2014) Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer, 120, 1345–1352.
23. Qin, C.D., Saha, S., Meacham, R. et al. (2014) Surgical risk after unilateral lobectomy versus total thyroidectomy: a review of 47 #bib434 patients. Surgery: Current Research, 4, 208.
24. Shrime, M.G., Goldstein, D.P., Seaberg, R.M. et al. (2007) Cost-effective management of low-risk papillary thyroid carcinoma. Archives of Otolaryngology-Head & Neck Surgery, 133, 1245–1253.
25. Landerholm, K., Wasner, A.M. & Jarhult, J. (2014) Incidence and risk factors for injuries to the recurrent laryngeal nerve during neck surgery in the moderate-volume setting. Langenbeck's Archives of Surgery, 399, 509–515.
26. Giordano, D., Valcavi, R., Thompson, G.B. et al. (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid, 22, 911–917.
27. Shan, C.X., Zhang, W., Jiang, D.Z. et al. (2012) Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. The Laryngoscope, 122, 797–804.
28. Vaiman, M., Nagibin, A., Hagag, P. et al. (2008) Hypothyroidism following partial thyroidectomy. Otolaryngology-Head and Neck Surgery, 138, 98–100.
29. Stoll, S.J., Pitt, S.C., Liu, J. et al. (2009) Thyroid hormone replacement after thyroid lobectomy. Surgery, 146, 554–558.
30. Centers for Medicare & Medicaid Services. Medicare reimbursement schedule. Available from: www.cmc.gov (accessed 4 Aug 2015).
31. Agency for Healtcare and Research Quality. Overview of the nationwide inpatient sample from the healthcare cost and utilization project. Available from: www.hcup-us.ahrq.gov. (accessed 4 Aug 2015).
32. National Cancer Institute. Surveillance, Epidemiology and End Results program. Available from: www.seer.cancer.gov. (accessed 4 Aug 2015).